Best Overall CRM Product Line

[Anonymous]

20% of how many reps 40? So what if you add 8 more reps. so you now have 1 per state. Again let me know when you get to 10% mrk shr. You'll have to let me know bc it wont happen in my accounts.

Biotronik has over 500 Direct sales reps and another 150 Independent reps working in the US. Most of these reps have been added in the last 3 years.

 

[Anonymous]

I don't know who has the best product line - and I don't really care. Let's not forget, there was a day when Teletronics had the best ICD on the market - it was the only one that had a VVI pacemaker in it.

If Medtronic/Boston/St Jude paid 20% commissions to independent reps - would anyone leave??? No, they pay 1.9% (Medtronic) and work you like a dog who should be thankful for the food they're given. Or you can try BSC, where plan changes every few months (go back to 2003-04).

CRM reps are no different than reps in any other industry - go to the company that pays the most in comms and see what happens.

I don't see too many pro athletes saying, "No, I'll stay with the team offering me $1m, even though you're offering me $15m to do the same job."

You guys can argue over product lines all day. I'll sit back and open my pay statement at the end of the month.

I suggest you ask your physician customers the following question - "If HMO A only paid you $250 for every device you put in and PPO C paid you $1000 - which insurance would you rather choose, and which insurance would you suggest your patients get?"

Sorry, but your analogy sucks. Bottom line, there is very little differentiation in terms of value added between payers (i.e. insurance companies). At the end of the day, they send a check. When it comes to the technology a physician is implanting in a patient, there are some notable differentiators. If I found out my loved one's physician chose company A over company B because they were being incentivized not due to the clinical benefits of one system over another...well I think you can guess where I am going with this. Try googling "hippocratic oath". It is amazing how some will rationalize their decisions/behavior for money. After you are done googling, rent "Less then Zero". Bio has some interesting technology and has made contributions in some niche areas. However, when it comes to standing toe to toe with BSX, MDT, and STJ, they fall short on many different levels. They will ALWAYS be a niche player. Buying business will only carry them so far. Sooner or later they will have to produce the goods. That doesn't mean that some of these whores they have hired wont make a few bucks at the expense of patients and physicians. JMHO.

 

[Anonymous]

Sorry, but your analogy sucks. Bottom line, there is very little differentiation in terms of value added between payers (i.e. insurance companies). At the end of the day, they send a check. When it comes to the technology a physician is implanting in a patient, there are some notable differentiators. If I found out my loved one's physician chose company A over company B because they were being incentivized not due to the clinical benefits of one system over another...well I think you can guess where I am going with this. Try googling "hippocratic oath". It is amazing how some will rationalize their decisions/behavior for money. After you are done googling, rent "Less then Zero". Bio has some interesting technology and has made contributions in some niche areas. However, when it comes to standing toe to toe with BSX, MDT, and STJ, they fall short on many different levels. They will ALWAYS be a niche player. Buying business will only carry them so far. Sooner or later they will have to produce the goods. That doesn't mean that some of these whores they have hired wont make a few bucks at the expense of patients and physicians. JMHO.

You make a very interesting point. How far does that keen eye for the “truth” stare into the industry though? When all of the other 3 companies offer an EP fellowship “grant” to a teaching institution for an unspoken commitment of business does that bother you?...Or when 1 of the 3 companies offer speaking engagements to physicians on a monthly often weekly basis does that bother you? Or when 2 of the other 3 companies offer implant registries for no real clinical data is that wrong? Or meeting locations that are just close enough to resort destinations that the doctors don’t mind the extra 30 minute drive to golf or ski even though as an industry we are not supposed to pay?
The fact is that Biotronik’s technology is on par or exceeds the other 3 companies out there. You may want to continue to spread this disinformation about alleged misconduct but I am sure that all companies have their share of skin the game if and when it comes to misconduct. Of Course if you have proof than you should turn those culprits in. I on the other hand will wait until some moron like you starts to through accusations around before I open the file of violations that I have witnessed by the other companies.
So grow up Mr. Hippocratic Oath and know that most physicians that work with one, two, three or all the companies really due feel they are doing what’s best for their patients. YOU SANCTIMONIOUS FUCK!
I suggest that you take a good look at yourself and the other people around you to find the real villains here...Those that through rocks in glass houses.

 

[Anonymous]

You make a very interesting point. How far does that keen eye for the “truth” stare into the industry though? When all of the other 3 companies offer an EP fellowship “grant” to a teaching institution for an unspoken commitment of business does that bother you?...Or when 1 of the 3 companies offer speaking engagements to physicians on a monthly often weekly basis does that bother you? Or when 2 of the other 3 companies offer implant registries for no real clinical data is that wrong? Or meeting locations that are just close enough to resort destinations that the doctors don’t mind the extra 30 minute drive to golf or ski even though as an industry we are not supposed to pay?
The fact is that Biotronik’s technology is on par or exceeds the other 3 companies out there. You may want to continue to spread this disinformation about alleged misconduct but I am sure that all companies have their share of skin the game if and when it comes to misconduct. Of Course if you have proof than you should turn those culprits in. I on the other hand will wait until some moron like you starts to through accusations around before I open the file of violations that I have witnessed by the other companies.
So grow up Mr. Hippocratic Oath and know that most physicians that work with one, two, three or all the companies really due feel they are doing what’s best for their patients. YOU SANCTIMONIOUS FUCK!
I suggest that you take a good look at yourself and the other people around you to find the real villains here...Those that through rocks in glass houses.

Very professional. I love how all of you Bio reps are grovelling to rationalize your decision to work for such a POS company. Good luck. You will need it.

 

[Anonymous]

Very professional. I love how all of you Bio reps are grovelling to rationalize your decision to work for such a POS company. Good luck. You will need it.

Not “groveling” just giving you the truth. Something you competitors have problems dealing in. Bio has great products and they do well in Patients every day.
Spelling must not have been covered in your Ivy league education.

 

[Anonymous]

Not “groveling” just giving you the truth. Something you competitors have problems dealing in. Bio has great products and they do well in Patients every day.
Spelling must not have been covered in your Ivy league education.

Didn't they tell you never to end a sentence in a preposition??? Douchenozzle.

 

[Anonymous]

Sorry, but your analogy sucks. Bottom line, there is very little differentiation in terms of value added between payers (i.e. insurance companies). At the end of the day, they send a check. When it comes to the technology a physician is implanting in a patient, there are some notable differentiators. If I found out my loved one's physician chose company A over company B because they were being incentivized not due to the clinical benefits of one system over another...well I think you can guess where I am going with this. Try googling "hippocratic oath". It is amazing how some will rationalize their decisions/behavior for money. After you are done googling, rent "Less then Zero". Bio has some interesting technology and has made contributions in some niche areas. However, when it comes to standing toe to toe with BSX, MDT, and STJ, they fall short on many different levels. They will ALWAYS be a niche player. Buying business will only carry them so far. Sooner or later they will have to produce the goods. That doesn't mean that some of these whores they have hired wont make a few bucks at the expense of patients and physicians. JMHO.

Are you serious? I have worked CRM in three major markets now, and have yet to see the Hippocratic Oath hold up to the lure of the All-Mighty Dollar.

Look. I can hardly blame these guys. On top of medical school and malpractice insurance, they have to keep their wives bamboozled with gobs of cash so they don't stop to realize how geeky these guys are.

I'll give you that SOME doctors are more straight-laced than others, but ultimately they have to get paid to stay in business. CMS payouts are barely keeping up with inflation, so they've GOT to make up the difference somewhere. Clinical studies are the answer. Not only do they offer a chance to pad the pocket, but they are also FDA-approved giving them the guise of legitimacy.

So, if you are suggesting that BIO is buying their business through clinical studies - then, fine. Guilty. But you can cram it up your ass if you are claiing that ANY other company out there is not engaged in the same practice.

You are dead-on with your assertion that we have some unique "niche" technology. It's SO unique that Boston buys it from us and sells it as their own, but beyond that BIO's problems have been pretty simple.

Not enough feet on the street.
Not enough penetration into the teaching institutions.

The layoffs at MDT and BSX have flooded the market with answers to the first problem.

The recent hiring of PN from BSX is the beginning of the solution for the second. If BIO can become part of an EP's Fellowship....

Look - we're easy to beat up. We are an underdog. But you know what - some guys like the underdog, and ultimately, I could give a Rat's Ass how a company does nationwide if I can pay my bills with the help of those physicians who value working with ME regardless of what's in my bag.

Good luck...

 

[Anonymous]

Are you serious? I have worked CRM in three major markets now, and have yet to see the Hippocratic Oath hold up to the lure of the All-Mighty Dollar.Look. I can hardly blame these guys. On top of medical school and malpractice insurance, they have to keep their wives bamboozled with gobs of cash so they don't stop to realize how geeky these guys are.I'll give you that SOME doctors are more straight-laced than others, but ultimately they have to get paid to stay in business. CMS payouts are barely keeping up with inflation, so they've GOT to make up the difference somewhere. Clinical studies are the answer. Not only do they offer a chance to pad the pocket, but they are also FDA-approved giving them the guise of legitimacy.So, if you are suggesting that BIO is buying their business through clinical studies - then, fine. Guilty. But you can cram it up your ass if you are claiing that ANY other company out there is not engaged in the same practice.You are dead-on with your assertion that we have some unique "niche" technology. It's SO unique that Boston buys it from us and sells it as their own, but beyond that BIO's problems have been pretty simple.Not enough feet on the street.Not enough penetration into the teaching institutions.The layoffs at MDT and BSX have flooded the market with answers to the first problem.The recent hiring of PN from BSX is the beginning of the solution for the second. If BIO can become part of an EP's Fellowship....Look - we're easy to beat up. We are an underdog. But you know what - some guys like the underdog, and ultimately, I could give a Rat's Ass how a company does nationwide if I can pay my bills with the help of those physicians who value working with ME regardless of what's in my bag.Good luck...

I have to say your reply was far more professional than 99% of the rest of the posts in this forum.* Fair enough on your counterpoints.* All companies are sponsoring trials and registries.* I don't have an issue with this.* Unfortunately for you, Bio has developed a rather poor reputation in a short period of time.* Anecdotally, the renumeration goes well beyond enrolling a physician as a study center.* That is the unfortunate thing.* Nuff said on that.

 

[Anonymous]

Are you serious? I have worked CRM in three major markets now, and have yet to see the Hippocratic Oath hold up to the lure of the All-Mighty Dollar.

Look. I can hardly blame these guys. On top of medical school and malpractice insurance, they have to keep their wives bamboozled with gobs of cash so they don't stop to realize how geeky these guys are.

I'll give you that SOME doctors are more straight-laced than others, but ultimately they have to get paid to stay in business. CMS payouts are barely keeping up with inflation, so they've GOT to make up the difference somewhere. Clinical studies are the answer. Not only do they offer a chance to pad the pocket, but they are also FDA-approved giving them the guise of legitimacy.

So, if you are suggesting that BIO is buying their business through clinical studies - then, fine. Guilty. But you can cram it up your ass if you are claiing that ANY other company out there is not engaged in the same practice.

You are dead-on with your assertion that we have some unique "niche" technology. It's SO unique that Boston buys it from us and sells it as their own, but beyond that BIO's problems have been pretty simple.

Not enough feet on the street.
Not enough penetration into the teaching institutions.

The layoffs at MDT and BSX have flooded the market with answers to the first problem.

The recent hiring of PN from BSX is the beginning of the solution for the second. If BIO can become part of an EP's Fellowship....

Look - we're easy to beat up. We are an underdog. But you know what - some guys like the underdog, and ultimately, I could give a Rat's Ass how a company does nationwide if I can pay my bills with the help of those physicians who value working with ME regardless of what's in my bag.

Good luck...

You're like a statistician, whose figures add up to nothing. Are you still smarting because you never made it to Med School. You are also guilty of an inability to spell "through accusations around" dunce!

Bio technology is not on par with BSX and Medt. It never will be.

Your academic failures will not be undone by trying to look intelligent on this board. It's over for you.

 

[Anonymous]

You're like a statistician, whose figures add up to nothing. Are you still smarting because you never made it to Med School. You are also guilty of an inability to spell "through accusations around" dunce!

Bio technology is not on par with BSX and Medt. It never will be.

Your academic failures will not be undone by trying to look intelligent on this board. It's over for you.

If thats the best you can come up with to counter this well spoken an honest argument then you lost. All companies have good and bad...I think we all know how low you fall in the spectrum of Sales Success.

 

[medpacer]

Biotronik currently has the best CRM product line on the market today.. Brady, Tachy, and CRT. They really put it together the last few years. Once the doctors really start looking into the technology, they are totally impressed. My only question, Why did it take so long to bypass the competition?

Biotronik is a joke. Anyone of the big 3 could come in and squash Bio like the cockroach they are. You clearly work for them or perhaps are being payed in some way by them (like most of the supporters), no one is in it for their 'technological advances.'

 

[Anonymous]

Biotronik is a joke. Anyone of the big 3 could come in and squash Bio like the cockroach they are. You clearly work for them or perhaps are being payed in some way by them (like most of the supporters), no one is in it for their 'technological advances.'

Well then the joke is on you RECALL BOY! I would love to read how the big 3 intend to squash us? Not going to happen as long as you all keep making shitty products...

 

[Anonymous]

Well then the joke is on you RECALL BOY! I would love to read how the big 3 intend to squash us? Not going to happen as long as you all keep making shitty products...

I believe the message is in the details. There clearly is a reason for Biotronik's lack of market share. If other companies were makeing the products described by you, that would not be the case would it?

 

[Anonymous]

I believe the message is in the details. There clearly is a reason for Biotronik's lack of market share. If other companies were makeing the products described by you, that would not be the case would it?

7% and climbing! Please tell us how your company intends to squash us as you stated above. Like most of your comments they lack any substance.

 

[Anonymous]

First, I am no tin the CRM industry.

The Big Three have been trying to no avail to squash Bio for years. Bio makes as good a product as anyone in the market place today. I would go as far to say that some of their products are even better than their competition's. Unfortunately, Bio got into the ICD market a little too late and missed the boat when the others were making BIG $$$$. During that time the markets share %'s fell into place. Now, it takes a large 7 number every month to steal 1% of market share. No, I do not have the exact number but the bean counters know exactly how much $$ is in the market in a given month, quarter and year. So, if Bio is in fact at 7% as somebody previously stated and they were only at 3-4% in the past year or so you better start doing the math because they are stealing market share from someone..... they are stealing it from the Big 3.

 

[Anonymous]

First, I am no tin the CRM industry.

The Big Three have been trying to no avail to squash Bio for years. Bio makes as good a product as anyone in the market place today. I would go as far to say that some of their products are even better than their competition's. Unfortunately, Bio got into the ICD market a little too late and missed the boat when the others were making BIG $$$$. During that time the markets share %'s fell into place. Now, it takes a large 7 number every month to steal 1% of market share. No, I do not have the exact number but the bean counters know exactly how much $$ is in the market in a given month, quarter and year. So, if Bio is in fact at 7% as somebody previously stated and they were only at 3-4% in the past year or so you better start doing the math because they are stealing market share from someone..... they are stealing it from the Big 3.

There is a direct relationship between the growth of BIO's US Market share and the rise of Obamacare.

 

[Anonymous]

There is a direct relationship between the growth of BIO's US Market share and the rise of Obamacare.

No, that is incorrect. The fact is all of the pacers and ICD's on the market work. Bio has expanded it's field force in most places so that it can adequately service its customers. When a company can offer comparable product and service on a level playing field, the decision to buy is all about price. Bio can beat the bloated "big 3" on price 100% of the time.

 

[Anonymous]

There is a direct relationship between the growth of BIO's US Market share and the rise of Obamacare.

You are nuts. a direct relationship between Bio's growth and Obamacare. LOFL!!!! 'Obamacare' is affecting every CRM company the same as Bio, In fact, it wasn't long ago that blowhards like yourself were touting that Obamacare would be the end of Biotronik because they would not be able to afford to pay the device tax. So, which is it? Is Obamacare killing Bio? It is benefiting Bio? If MDT and BSX are so solid and strong then why are they laying people off left and right? Oh yeah, they are 'right sizing'. Well, Bio is right sizing too. They are taking on more talent (some good and some bad) and are stealing market share away. They are taking a little here and a little there but they are doing it. It is adding up. Will it ever add up to 10%, 20% or 40%? Maybe not but they do not answer to the pressures from shareholders to turn profits. They don't have to market a failing lead to turn a profit because they don't have a Plan B.

Product vs. Product... it is a tight race across the board. The lack of service, the inferior products, and the "they're buying business jabs" have all been thrown at Bio but yet they still slowly and quietly move along. For any CRM (including Bio) to come onto CP and bang their chest is laughable.

 

[Anonymous]

7% and climbing! Please tell us how your company intends to squash us as you stated above. Like most of your comments they lack any substance.

No need to. 7% lacks substance.

 

[Anonymous]

No need to. 7% lacks substance.

7% lacks substance????? First, is Bio really at 7%? I know that Bio held 3-4% in recent years (2010 - 2011). So, if they are at 7% today then they took 3-4% from somebody in a short period of time. The previous poster is correct in that it takes a huge number just to gain 1% market share in the US CRM market. And no, I do not know what the exact number is either. I am sure somebody out there knows what that number is. My point being that IF Bio did in fact gain 3-4% then they took it from somewhere and there is substance in that. Maybe the 'Big 3' are not as big as they once were. SJM certainly isn't.